The expression of mH chain is an important checkpoint in B cell development. In mice de®cient for IgM transmembrane tail exons (mMT mice) B cell development is blocked at the pro-B stage. However, we showed that Fas-de®cient mMT mice (mMT/lpr) develop a very small population of isotype-switched B cells and produce high titers of self-reactive serum antibodies. In addition, mMT/lpr mice develop severe lymphoproliferation and both pathologic processes occur at young ages. This may suggest that lack of Fas±Fas ligand signaling exacerbates murine lupus in B cell lymphopenic mice. To test this we analyzed antibody and plasma cell formation, and accumulation of abnormal T cells in mMT/lpr mice. Our results show that the mMT/lpr mouse is particularly permissive for the development and accumulation of antibody-producing cells, thereby explaining the high titers of serum antibodies in these mice. In addition, we found that accumulating cells in spleen and lymph nodes of mMT/lpr mice are ab T cells expressing the abnormal B220 + /CD3 + surface markers, a phenotype also described for other Fas-de®cient mouse models. Strikingly, we found that accumulating cells in mMT/lpr mice express the membrane proteoglycan syndecan-1, a known plasma cell marker. Development of these cells is blocked in mice de®cient for TCRb and TCRd. We also found that both antibody production and lymphoproliferation in mMT/lpr mice are T h 1 regulated. Our results, therefore, suggest that in the mMT/lpr mouse model a small population of isotype-switched B cells is suf®cient for the initiation and propagation of T h 1-regulated murine lupus.
Introduction
B cell development is a process strictly regulated by Ig gene rearrangements and assembly (1, 2) . The requirement of functional Ig heavy and Ig light expression and signaling in promoting B cell development has been shown in several models of mutated mice, in which B cell development in the bone marrow (BM) is blocked or altered (reviewed in 2,3). In addition, B cell development is limited by negative selection, imposed by self-tolerance mechanisms (2, 4, 5) . Thus, B lymphocytes expressing incompetent receptors are subjected to negative selection and are eliminated by apoptosis.
Fas (CD95) is a surface receptor that transmits apoptotic signals upon binding of Fas ligand (FasL) in a wide variety of cell types (6) and is particularly important in controlling activated lymphocytes (7±9). However, in contrast to its known function in mature cells, the role of Fas signaling in developing lymphocytes is unclear. Several studies in Ig transgenic (Tg) mice failed to demonstrate a role for the Fas pathway in negative selection and elimination of developing B cells (10±12). Mice de®cient for functional Fas or FasL (lpr/ lpr or gld/gld respectively) develop an autoimmune lupus-like disease, which is characterized by production of high titers of autoantibodies in serum, immune complex glomerulonephritis, vasculitis and arthritis (13) . In addition, lack of functional Fas signaling in these mouse models is also characterized by massive accumulation of abnormal CD3 + T lymphocytes that aberrantly express B220, and lack expression of CD4 or CD8 (13) . Many studies have utilized these mouse models to show that both T and B lymphocytes are required for the onset and propagation of the disease (14±16).
In early studies we used mice de®cient for the IgM transmembrane tail exon (mMT), in which B cell development is blocked at the pro-B stage (17) , to probe the role of Fas in the negative selection of developing B cells (18) . Strikingly, we found that Fas-de®cient mMT mice (mMT/lpr) develop a very small population of isotype-switched, mature Ig + B cells and produce high titers of self-reactive serum antibodies. In addition, mMT/lpr mice develop severe lymphoproliferation. Both production of autoantibodies and lymphadenopathy occur in young mMT/lpr mice (8±10 weeks) (18) , suggesting that partial B cell lymphopenia exacerbates murine lupus in this mouse model. In the present work further steps have been taken to de®ne the pathological and immunological symptoms that develop in the mMT/lpr model. We found that the mMT/lpr mouse is particularly permissive for the development and accumulation of antibody-producing cells, thereby explaining the high titers of serum antibodies in these mice. In addition, we found that the abnormal cells accumulating in spleen and lymph nodes (LN) of mMT/lpr mice express the membrane proteoglycan syndecan-1. The function of this molecule in these T cells is yet to be explored. Such cells did not develop in T cell-de®cient mMT/lpr mice. We also found that the antibody response and lymphoproliferation in mMT/lpr mice are T h 1 regulated. Collectively, our results suggest that in the mMT/lpr mouse model a small population of isotype-switched B cells is suf®cient for the initiation and propagation of T h 1-regulated murine lupus.
Methods

Mice
Normal [C57/BL6 (B6)], Igm-de®cient (B6-mMT/mMT), Fasde®cient (B6-Faslpr/Faslpr) and TCRb/TCRd-de®cient (B6-TCRbd ±/± ) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). Mice de®cient for Igm and Fas (mMT/lpr) were generated by crossing mMT and lpr mice. In some experiments mMT/lpr mice were crossed with TCRbd ±/± mice to generate mMT/lpr/TCRbd ±/± mice. Mouse typing for mMT and lpr was performed by PCR as described (18) . Typing for TCRd de®ciency was performed by PCR (primer sequences as published by the Jackson Laboratory) and for TCRb by¯ow cytometry. Mice were maintained under speci®c pathogenfree conditions at the animal facility.
Analysis of serum antibody
Titers of total IgG, IgG1, IgG2a, IgM, k and l in serum samples were determined by sandwich ELISA, using speci®c goat antimouse polyclonal reagents (Southern Biotechnology Associates, Birmingham, AL) as we have described (18) .
Puri®ed antibody of each isotype tested provided the standard curve for calculation of antibody concentration.
ELISPOT
Detection of antibody-forming cells (AFC) by ELISPOT assay was performed as described (19) . Brie¯y, 5-cm nitrocellulose ®lters were placed in 5-ml tissue culture Petri dishes, and coated overnight with a mixture of polyclonal goat anti-mouse k and goat anti-mouse l (2.5 mg/ml) (Southern Biotechnology Associates). After an extensive wash (0.1% Tween 20/PBS), ®lters were blocked with 5% BSA for 2 h, and washed twice with PBS and twice with IMDM (Gibco/BRL, Gaithersburg, MD) prior to cell addition. Spleen cells, red blood cell-depleted and resuspended in IMDM, were cultured at different concentrations on top of ®lters for 12±16 h. After incubation, ®lters were extensively washed and incubated with biotinylated goat anti-mouse IgG (g chain-speci®c) antibody. Streptavidin conjugated with horseradish peroxidase was used as a secondary probe and signals were generated by the ECL reaction. Spots generated on ®lm were counted and frequency was calculated.
Flow cytometry
Single-cell suspensions from spleen and LN were stained for surface marker expression using FITC-, phycoerythrin (PE)-and biotin-conjugated antibodies, visualized with streptavidin TriColor (Caltag, San Francisco, CA). Antibodies used for cell staining were: CD19 (clone 1D3), TCRb (clone H57), TCRd (clone GL3), syndecan-1 [(CD138), clone 281-2] (all from PharMingen, San Diego, CA), B220 (clone RA3-6B2; Southern Biotechnology Associates) and CD3 (clone KT3; Serotec, Oxford, UK). Data for three-color analysis were collected on a FACSCalibur and analyzed using CellQuest software (Becton Dickinson, Mountain View, CA).
Intracellular cytokine staining and analysis
Intracellular staining for spleen and LN was performed as we have described (20) . Brie¯y, spleen and LN cells were stimulated with phorbol myristate acetate (50 ng/ml), ionomycin (0.2 mM) and monensin (0.2 mM) for 5 h (all from SigmaAldrich, St Louis, MO). Stimulated cells were ®rst stained for surface expression of B220 and syndecan-1. For intracellular cytokine stain, membranes were ®rst lysed with saponin (0.5%), followed by incubation with PE-labeled rat antimouse IFNg mAb and allophycocyanin-labeled rat antimouse IL-4 mAb (all from PharMingen). Cells were analyzed using a FACSCalibur.
Results
Abnormal serum antibody production in mMT/lpr mice Mice bearing the mMT mutation fail to produce mature B cells in the BM and completely lack serum IgM or IgG (Fig. 1A ) (17, 18) . However, lack of functional Fas rescues the development of some isotype-switched B cells, resulting in a signi®-cant 3-to 4-fold increase in the production of serum IgG relative to normal mice (Fig. 1A) . To study the nature of this unexpected antibody response we performed isotypic analysis on serum samples collected from mMT/lpr mice, relative to serum from normal mice (Fig. 1B) . Light chain analysis clearly showed that antibody responses in mMT/lpr mice are nonhomogenic. We found that the Igl proportion in mMT/lpr sera was widely distributed, ranging from 0 to 30%, whereas the proportion of Igl antibodies in normal serum is only 2±4%. Interestingly, most mMT/lpr mice produced signi®cantly elevated levels of Igl (up to 10-fold) relative to control. Similarly, we found non-homogenic distribution in Ig heavy isotypic analysis in mMT/lpr serum samples relative to control (not shown). The unique pattern of serum antibody distribution in each mMT/lpr mouse may suggest a selection process of particular B cell clones.
Accumulation of abnormal T cells in spleen and LN of mMT/lpr mice
The development of severe lymphadenopathy in mMT/lpr occurs at a young age (18) . Interestingly, we did not detect enlarged spleens in mMT/lpr mice (not shown). However, FACS analysis of spleen cells revealed a massive accumulation of abnormal CD3 + /B220 + T lymphocytes (Fig. 2, top) . In contrast to mMT and normal mice, where the number of these cells was very low, the abnormal T cell population in the mMT/ lpr mice reached 50±70% (Fig. 2, top) and severity of accumulation increased with age (not shown). Further surface analysis revealed that accumulating B220 + /CD3 + T cells in mMT/lpr spleens are ab, but not gd, T cells (Fig. 2, top) . As shown earlier (18) , the B cell population in the mMT and mMT/ lpr (B220 + /CD19 + ) is relatively low (2.5±5%, Fig. 2) . A similar distribution of lymphocyte populations was found in peripheral LN of these mice (Fig. 2, bottom) . The possibility that abnormal T cell accumulation in the mMT/lpr mice results from B cell lymphopenia is unlikely since such cells are not found in the mMT spleen and LN. Thus, as described for the lpr mouse model, this accumulation exclusively depends on lack of Fas signaling.
Increased frequency of plasma cells in mMT/lpr mice To resolve the apparent contradiction between the very high titers of serum antibody, on the one hand, and the low number of Ig + cells in mMT/lpr mice (18), on the other hand, we studied the frequency of plasma cells in mMT/lpr mice. To do so, two approaches had been taken: FACS analysis and direct detection of AFC by the ELISPOT method. Since syndecan-1 is used as a plasma cell marker, spleen cells from normal, mMT and mMT/lpr mice were analyzed for the expression of syndecan-1, and the pan-B cell markers B220 and CD19. Unexpectedly, we found a severe accumulation of cells expressing both B220 and syndecan-1 in spleens of mMT/lpr mice (~50% of the cells, Fig. 3A ). Similar accumulation of B220 + /syndecan-1 + cells was also evident in mMT/lpr LN (not shown). Further analysis for CD19 expression clearly showed that only a small fraction of these cells were indeed B lymphocytes, while the majority were not (not shown). Hence, to quantify AFC by syndecan-1 expression, we analyzed gated B220 + /CD19 + spleen cells (Fig. 3B) . The results showed that 20±25% of the B cells in mMT/lpr spleens expressed syndecan-1 and were considered as plasma cells, relative to only 1±1.5% plasma cells in normal mouse. Calculating the absolute numbers revealed that mMT/lpr mice had a 2.5 T 0.9-fold increase in AFC number. As expected, such cells were essentially not detected in mMT spleens ( Fig. 3A and B) . To con®rm and further visualize these ®ndings we analyzed IgG AFC in spleens of these mice by ELISPOT. The results, which are presented in Fig. 3(C) , clearly show increased AFC in mMT/lpr mice. Upon counting the spots Light chain analysis in normal and mMT/lpr serum samples. The concentrations of k and l light chains were determined by ELISA. Shown is the k:l distribution for individual mice, plotted as k on the x-axis relative to l on the y-axis. All Ig concentrations were determined using an appropriate standard curve. we calculated that the AFC frequency in mMT/lpr mice is 3-to 3.5-fold higher relative to normal (344 T 70 in mMT/lpr relative to 102 T 25 in normal), results that were not signi®cantly different from those obtained by syndecan-1 staining and FACS analysis. For comparison, in wild-type B6/lpr mice at the early onset of the lpr disease, we obtained 2.5-to 3.5-fold increase in numbers of plasma cells as measured both by FACS ( Fig. 3A and B ) and by ELISPOT (Fig. 3C) , and this is in agreement with earlier studies (21) . We concluded that differentiation of B lymphocytes to plasma cells is augmented in the mMT/lpr mice and may be associated with the early onset of the disease.
Accumulating B220 + /CD3 + abnormal T lymphocytes in mMT/lpr mice express syndecan-1
The large population of B220 + cells expressing syndecan-1, which was unexpectedly detected in mMT/lpr mice, was further studied to identify this cell subset. Because of the large fraction of these cells, we speculated that most of the syndecan-1 expression is a unique feature of the abnormal T cell population accumulating in the mMT/lpr mouse. To test this hypothesis we analyzed syndecan-1 expression in gated abnormal (CD3 + /B220 + ) T lymphocytes relative to the normal (CD3 + /B220 ± ) T cell population in mMT/lpr mice. Similar comparative analysis was performed for wild-type B6/lpr mice at the early onset of the lpr disease. The results in Fig. 4 unambiguously show that >80% of the abnormal T cell population in spleen (top) and LN (bottom) in mMT/lpr mice is expressing syndecan-1. Interestingly, while abnormal T cells accumulating in LN of B6/lpr mice also express syndecan-1, we did not detect signi®cant expression of syndecan-1 in the abnormal T cells accumulating in spleen of the B6/lpr mice (Fig. 4) . As expected, normal T cells in both mMT/lpr and B6/lpr did not express syndecan-1. Hence, we show here for the ®rst time that abnormal T lymphocytes accumulating in spleen and LN of mMT/lpr mice and in LN of B6/lpr mice express the membrane proteoglycan syndecan-1.
Lack of B220 + /CD3 + /syndecan-1 + cell accumulation in mMT/lpr mice de®cient for ab and gd T lymphocytes
To test whether accumulation of B220 + /CD3 + /syndecan-1 + cells in the mMT/lpr mouse depends on T lymphocytes, we crossed the mMT/lpr mice with mice genetically de®cient for functional b and d TCR chains to generate mMT/lpr/TCRbd ±/± mice. This approach completely abolished the development of mature T lymphocytes, as evident by the lack of CD3 + cells (Fig. 5) . Analysis of spleen (Fig. 5) and LN (not shown) in these mice clearly showed that accumulation of B220 + /CD3 + / syndecan-1 + cells is T cell dependent. The abnormal B220 + / CD3 + /syndecan-1 + cells were completely absent in spleen and LN of mMT/lpr/TCRbd ±/± mice, relative to the T cellsuf®cient mMT/lpr mice. A predominant T h 1 response in mMT/lpr mice To determine the type of abnormal immune responsiveness that developed in mMT/lpr mice we analyzed cytokine and serum antibody production. Spleen and LN cells from normal, mMT and mMT/lpr mice were stained for surface syndecan-1 expression, and intracellular IFN-g (a T h 1-regulated cytokine) and IL-4 (a T h 2-regulated cytokine) production. FACS analysis of spleen cells clearly showed that accumulating syndecan-1 + cells also produce IFN-g, but not IL-4, suggesting a biased T h 1 responsiveness (Fig. 6A) . Similar results were also obtained in LN (not shown). Serum antibody analysis con®rmed this observation by showing increased IgG2a (T h 1-regulated antibody) and decreased IgG1 (T h 2-regulated antibody) in mMT/lpr mice (Fig. 6B) . This is in contrast to a reciprocal IgG2a:IgG1 ratio found in a normal mouse (Fig. 6B) . Since the antibody repertoire in the mMT/lpr mice is limited and selfreactive (18), the biased IgG2a production strongly supports the fact that a predominant T h 1-type responsiveness develops in these mice. Thus, both autoimmunity and lymphoproliferation in the mMT/lpr mouse model are T h 1 mediated, as described in other Fas-de®cient lpr models (22, 23) .
Discussion
Lack of Fas±FasL signaling results in a severe autoimmune response in the lpr and gld mouse models, and both T and B cells are required for it (13±16). It is therefore surprising to ®nd that a small subset of isotype-switched B cells, capable of developing in mMT/lpr and in mMT/gld mice (18) , gives rise to high titers of anti-DNA serum IgG. The present study shows that the autoimmune-prone mMT/lpr mice are particularly permissive for the accumulation of AFC, thereby exacerbating the lupus-like disease. These mice also develop severe lymphoproliferation of abnormal T cells expressing the membrane proteoglycan molecule syndecan-1. While this study does not rule out the requirement of both T and B cells for murine lupus, it indicates that a small subset of isotypeswitched B cells is suf®cient for its initiation and propagation. The development of these B cells is Fas±FasL dependent.
The generation of serum IgG in mMT/lpr mice indicates that the process of isotype switching can circumvent the developmental block imposed by the mMT mutation. Indeed, earlier studies showed that a small population of isotype-switched Ig + B cells is present in mMT/lpr spleens (18) and switching to IgA occurs in mMT mice in response to intestinal stimulation (24) . BM analysis of mMT/lpr mice does not reveal a substantial change in the developmental block imposed by the mMT mutation (18) . This may suggest that isotype switching occurs at very low frequency during development and such cells accumulate in the periphery. Studies showing spontaneous isotype switching in transformed B cell lines (25) support this hypothesis. Alternatively, isotype switching in mMT/lpr mice may occur in the periphery since many pro-B cells are found in spleen and LN of these mice (17, 18) . Studies show that under appropriate stimulation, isotype switching can be induced in Ig ± B cells (26) , and that sIg ± B cells can participate in the germinal center reaction and acquire somatic mutations (27) or undergo receptor revision and express autoimmune speci®city (28) . Nevertheless, this process is inef®cient in the mMT/ lpr mice, also resulting in a non-homogenic antibody production as re¯ected by differential distribution of IgG isotypes between mice (18) and in the k:l ratio (Fig. 1) . It is possible, though, that such non-homogenic responses re¯ect a process of selection that may be different between mice. The ®nding 
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at Pennsylvania State University on February 23, 2013 http://intimm.oxfordjournals.org/ that mMT/lpr mice develop a self-reactive antibody repertoire supports this hypothesis (18) . Strikingly, we found that despite the very small numbers of Ig + cells, the mMT/lpr mice provided a permissive environment for accumulation of AFC, resulting in a 2.5-to 3.5-fold increase relative to a normal mouse. While this may explain the apparent high titers of IgG in sera of these mice, it may also indicate a major process of clonal selection and expansion. This notion is supported by the ®ndings that mMT/lpr mice have a limited repertoire and they fail to respond to exogenous antigens (18) . Thus, isotype switching may allow B cells to develop, but subsequent selection proliferation and differentiation to plasma cells are augmented in the mMT/lpr mouse. Earlier studies have shown that autoimmune prone mice, including the MRL strain, develop 3-to 6-fold more plasma cells during the onset of the autoimmune disease (21) . In these mice, however, accumulation of plasma cells is due to initial polyclonal activation originating from a normal-sized B cell population (13) , whereas in mMT/lpr mice the Ig + B cell pool is 1±5% of the normal size (18) . Thus, plasma cell accumulation in the mMT/lpr lymphopenic mice is a remarkable observation that may result from enhanced processes of clonal selection and expansion. In most cases all of these processes are linked to the germinal center reaction and are mediated by T cell help (1) . However, recent data suggest that isotype switching, memory formation and acquisition of somatic mutations can occur outside the germinal center (29, 30) . Peripheral activation is thought to be an important mechanism for B cell tolerance, as lack of T cell help promotes B cell apoptosis mediated by Fas signaling (1, 31, 32) . This may suggest that lack of Fas allows a permissive environment for selection and activation of autoreactive clones into the B cell follicle (33, 34) or at the T zone/red pulp border (30) , thereby leading to breakdown of self-tolerance. Similarly, in Ig Tg models, lack of Fas results in development of a small population of variant B cells, bearing non-Tg speci®city, that undergo activation and isotype switching to produce high titers of anti-DNA antibodies (10, 11) . In Fas-de®cient mice B cell expansion and autoimmunity involves T cell-dependent [both ab and gd T cells (35±37)] and T cell-independent mechanisms (11, 38) , resulting in a gradual increase in serum IgG with age. However, lack of secreted IgM accelerates IgG autoantibody production and autoimmune disease in MRL/lpr mice de®cient for secreted IgM (39) . This may explain the signi®cant accumulation of plasma cells and high titers of autoimmune serum IgG that develop early in mMT/lpr mice.
Lack of Fas or FasL also results in accumulation of abnormal B220 + /TCR + /CD4 ± /CD8 ± T cells in spleen and LN of lpr mice (13) . This pathologic process appears to be independent of B cells, as such cells also accumulate in lpr mice bearing a complete deletion of the J H locus, where B cell development is completely blocked (16, 40) . The origin of these cells is not clearly de®ned. Early studies propose that these abnormal T cells originate from thymic precursors (41, 42) . More recent work suggests that these cells are post-activated T cells surviving due to lack of functional Fas signaling (43±45), as T cells undergoing superantigen-induced apoptosis in vivo express B220 and Fas (46) , and Tg expression of Fas in T cells blocks lymphoproliferation in MRL/lpr mice (47) . We found a severe lymphoproliferation of abnormal T cells expressing ab, but not gd, TCR in the mMT/lpr mice (Fig. 2) . Accumulation of these cells is accelerated in the mMT/lpr mice and obtained even in young mice (18) . This may suggest an important role for the small number of selected mMT/lpr B cells in priming T lymphocytes and induction of autoimmunity, a paradigm proposed by Shlomchik et al. (40) . It is also in agreement with studies showing a central role for ab T cells in the pathogenesis of murine lupus (35, 36) and reduced lymphoproliferation obtained in TCRa ±/± /lpr mice (48) . Other studies in T-de®cient mice implicated an important role for gd T cells in regulating murine lupus (35, 48) .
We show here, for the ®rst time, that abnormal T cells accumulating in Fas-de®cient mice express the transmembrane proteoglycan syndecan-1 (Fig. 4) . In the mMT/lpr mice syndecan-1 was signi®cantly expressed by abnormal B220 + / CD3 + T cells accumulating in both spleen and LN. It is clear that these cells arise from T lymphocytes, as they could not be found in mMT/lpr mice de®cient for b and d TCR (Fig. 5) . We could also detect syndecan-1 expression in abnormal T cells accumulating in LN of B6/lpr mice, but not on those accumulating in the spleen. Syndecans are widely expressed on the surfaces of most cells in the body, and play an important role in cell±matrix and cell±cell interactions, as well as modulating receptor activation (49, 50) . In hematopoietic cells syndecan-1 is know to be expressed not only on pre-B and plasma cells, but also on malignant B lymphoid cells, although its functionality in these cells has not been de®ned yet (49, 50) . That abnormal T cells in the mMT/lpr mouse express signi®cant levels of syndecan-1 may imply an important role of this molecule in directing these cells into the peripheral lymphoid tissue. Several studies show that syndecans may act as coreceptors in a variety of physiological processes, including cell adhesion, migration, response to growth factors, development and tumorigenesis (reviewed in 51). Recent in vitro and in vivo data suggest the involvement of syndecans in the modulation of leukocyte±endothelial interactions and extravasation during in¯ammation (52) , and in mediating HIV infection (53) . Hence, the expression of syndecan-1 may also explain the altered responsiveness of this abnormal T cell population to a variety of stimulations (54, 55) and the defective traf®c patterns (56) . This, however, may result from complex modi®cations in additional surface or intracellular regulatory genes that are yet to be de®ned. So far, syndecan-1 has not been shown to be expressed by T cells nor has its possible involvement in pathogenesis of murine lupus been demonstrated. As this molecule is involved in regulating cell migration (51, 52) it may also act, perhaps with other molecules, in directing the abnormal T cells to accumulate in peripheral lymphoid organs. It is possible, though, that expression of syndecan-1 is associated with pathogenicity of the T cells, and the differential expression of this molecule in LN and spleen of B6/lpr mice supports this possibility. The fact that in mMT/lpr mice syndecan-1 is expressed in both spleen and LN abnormal T cells may re¯ect the exacerbation of the disease in these mice. This hypothesis, as well as the function of syndecan-1 on these abnormal T cells, is yet to be elucidated.
Autoimmunity in Fas-de®cient mice is characterized by the production of autoantibodies and nephritis, and both require B and T lymphocytes. In murine lupus, B lymphocytes have been shown to serve as antigen-presenting cells and autoantibody producers in mediating renal lymphocytic in®ltration (14, 16, 40) . This is regulated by CD4 T cells, as lpr mice de®cient for CD4 or MHC class II do not produce autoantibodies and develop only moderate nephritis (37, 57) . In contrast, all these mice develop B220 + /CD3 + abnormal T cell lymphoproliferation, suggesting that autoimmunity and lymphoproliferation are independent processes developing in Fas-de®cient mice. This is supported by showing that lymphoproliferation is reduced in lpr mice de®cient for MHC class I, lacking CD8 T cells (58) . Early studies suggested that murine lupus in the lpr mouse is regulated by imbalance towards T h 1 predominant responses (22, 23) . In agreement with these are our ®ndings showing that abnormal, syndecan + T cells accumulating in the mMT/lpr mice produce IFN-g and not IL-4 (Fig. 6) . Since the antibody repertoire of these mice is limited (18) , the signi®cant increase in T h 1-regulated antibodies (IgG2a) obtained in the mMT/lpr mice, relative to the T h 2-regulated antibodies (IgG1), strongly supports and further extends these observations. This may suggest that dominant T h 1 responses, initiated in the absence of functional Fas, promote a permissive environment in which self-reactive B lymphocytes are produced and selected to participate in an autoimmune response (34) . In the mMT mice this is particularly important since B cell development is blocked at the pro-B stage and maturation is limited by isotype-switching requirements. However, the mechanism of development and selection of these cells is still unknown.
